The University of Oxford has launched the first human trial of a vaccine against <a href="https://www.mid-day.com/news/world-news/article/ebola-outbreak-congo-death-toll-crosses-520-who-warns-outbreak-is-intensifying-23638833" target="_blank" rel="nofollow noopener">Bundibugyo ebolavirus</a> to combat an outbreak in the Democratic Republic of Congo and Uganda.
The early-stage trial will evaluate the safety and immune response of the ChAdOx1 BDBV vaccine in 50 healthy adults aged 18 to 55 in Oxford.&nbsp;
Recruitment has begun, with vaccinations expected to start in the coming weeks pending regulatory approval.&nbsp;
The vaccine was developed by Oxford scientists using the same viral vector platform as the Oxford/AstraZeneca COVID-19 shot.
This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever

The University of Oxford has launched the first human trial of a vaccine against Bundibugyo ebolavirus to combat an outbreak in the Democratic Republic of Congo

University of Oxford begins human testing of new Ebola vaccine

Astronomers detect key star formation process inside Taurus molecular cloud

Recruitment has begun, with vaccinations expected to start in the coming weeks pending regulatory approval

Oxford launches first human trial of vaccine against Bundibugyo ebolavirus

Trending Stories

Latest Photos

Latest Videos

Latest Web Stories

Ganeshotsav 2026

Home / News / World News / Article / Oxford launches first human trial of vaccine against Bundibugyo ebolavirus